´ëÇÑÁ¾¾ç³»°úÇÐȸ Best of San Antonio Breast Cancer Symposium (SABCS) 2021 in Korea : 2022-01-29±³À°ÀÏÀÚ : 2022-01-29
±³À°Àå¼Ò : ¼¿ïµå·¡°ï½ÃƼ ÇѶó
±³À°ÁÖÁ¦ :
Best of San Antonio Breast Cancer Symposium (SABCS) 2021 in KoreaÁÖÃÖ±â°ü : ´ëÇÑÁ¾¾ç³»°úÇÐȸ(17.5 ¸íĪº¯°æ Çѱ¹ÀÓ»ó¾ÏÇÐȸ)
´ã´çÀÚ : ´ëÇÑÁ¾¾ç³»°úÇÐȸ
¿¬¶ôó : 02-735-2857
À̸ÞÀÏ :
meetings@ksmo.or.kr ±³À°Á¾·ù : ³»°ú, ¿µ»óÀÇÇаú, ¹æ»ç¼±Á¾¾çÇаú, º´¸®°ú
Âü¼®¿¹»óÀοø : 250¸í
Èñ¸ÁÆòÁ¡ : 6Á¡
Áö¿ª :
¼¿ïƯº°½Ã±³À°½Ã°£ : 6 ½Ã°£ 55ºÐ
¼¼ºÎ¼ö°·á : 80,000¿ø
ºñ°í »çÀüµî·Ï : Àü¹®ÀÇ 50000¿ø ÀüÀÓÀÇ 30000 ¿ø ±âŸ 70000¿ø ´çÀϵî·Ï : Àü¹®ÀÇ 60000¿ø ÀüÀÓÀÇ 40000 ¿ø ±âŸ 80000¿ø
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 01-29 ÇѶó 09:00~09:25 Discoveries in metastasis biology and tumor microenvironment ÀÌ´ë¿ø(¼¿ïÀÇ´ë)
±³À°½Ã°£ 01-29 ÇѶó 09:25~09:50 Immune landscape in breast cancer ±è¹Îȯ(¿¬¼¼ÀÇ´ë)
±³À°½Ã°£ 01-29 ÇѶó 09:50~10:15 Dynamic ctDNA and genomic profiles to monitor response prediction ÀÌÁöÀº(°¡Å縯ÀÇ´ë)
Åä·Ð 01-29 ÇѶó 10:15~10:30 Q & A ()
ÈÞ½Ä 01-29 ÇѶó 10:30~10:45 Coffee break ()
±³À°½Ã°£ 01-29 ÇѶó 10:45~11:10 AI applied to imaging and biopsy TBD(TBD)
±³À°½Ã°£ 01-29 ÇѶó 11:10~11:35 Optimal loco-regional surgical management : Reducing the impact of axillary surgery ¹Ú¼¼È£(¿¬¼¼ÀÇ´ë)
±³À°½Ã°£ 01-29 ÇѶó 11:35~12:00 Updates in Radiotherapy : Should one week of RT be standard of care? ÀåÁö¼®(¿¬¼¼ÀÇ´ë)
±³À°½Ã°£ 01-29 ÇѶó 12:00~12:25 Highlights of survivorship and lifestyle modification °í¼öÁø(¿ï»êÀÇ´ë)
Åä·Ð 01-29 ÇѶó 12:25~12:40 Q & A ()
±³À°½Ã°£ 01-29 ÇѶó 12:40~13:10 TBD ÀÓ¼®¾Æ(¼¿ïÀÇ´ë)
ÈÞ½Ä 01-29 ÇѶó 13:10~13:30 Coffee break ()
±³À°½Ã°£ 01-29 ÇѶó 13:30~13:55 Optimal adjuvant endocrine treatment for HR+/HER2- EBC ±èÇÑÁ¶(¼øõÇâÀÇ´ë)
±³À°½Ã°£ 01-29 ÇѶó 13:55~14:20 Refining (neo)adjuvant immunotherapy and chemotherapy ¹ÚÀÎÇý(°í·ÁÀÇ´ë)
Åä·Ð 01-29 ÇѶó 14:20~14:30 Q & A ()
ÈÞ½Ä 01-29 ÇѶó 14:30~14:45 Coffee break ()
±³À°½Ã°£ 01-29 ÇѶó 14:45~15:10 Advanced in systemic treatment options for HER2+ ABC ½É¼ºÈÆ(±¹¸³¾Ï¼¾ÅÍ)
±³À°½Ã°£ 01-29 ÇѶó 15:10~15:35 Novel SERDs, CDK inhibitors and beyond in advanced HR+/HER- ABC ±èÁöÇü(¿¬¼¼ÀÇ´ë)
Åä·Ð 01-29 ÇѶó 15:35~15:45 Q & A ()
±³À°½Ã°£ 01-29 ÇѶó 15:45~16:10 Therapeutic advances and new directions for TNBC ¹Ú°æÈ(°í·ÁÀÇ´ë)
±³À°½Ã°£ 01-29 ÇѶó 16:10~16:35 New agents on the horizon ÀÌ°æÀº(ÀÌÈÀÇ´ë)
Åä·Ð 01-29 ÇѶó 16:35~16:45 Q & A ()